Write us    Phone: 250-595-1551    Fax: 250-595-1000
Write us    Phone: 250-595-1551    Fax: 250-595-1000

Dr. Olivier Desplantie

Dr Olivier Desplantie

Dr. Olivier Desplantie

M.D.C.M, F.R.C.P.C

CLINICAL INTERESTS

  • Advanced Heart failure
  • Cardiac transplantation
  • Cardiac rehabilitation and prevention
  • Hypertrophic cardiomyopathy
  • Peripartum cardiomyopathy
  • Cardiac sarcoidosis
  • Cardiac amyloidosis

RESEARCH INTERESTS

  • Desplantie O, Ramanathan K, Daskalopoulou SS, Eisenberg M, Pilote L, Khan NA. Can Apolipoproteins apoB and apoB/apoA1 Ratio Predict Future Cardiovascular Risk Post Acute Coronary Syndrome? A Retrospective Cohort Study. J Clin Exp Cardiolog 2016, 7:5.
  • Desplantie O, Tremblay-Gravel M, Avram R, Marquis-Gravel G, Ducharme A, Jolicoeur EM. The Medical Treatment of New Onset Peripartum Cardiomyopathy; a Systematic Review of prospective studies. Canadian Journal of Cardiology, Volume 31, Issue 12, 1421 – 1426. Editorial by Dr. R. Cardona-Guarache and Dr. J. Kron.
  • Desplantie O, Filion KB, Eisenberg MJ. Perspectives on the Clinician-Scientist Pathway: A Survey of Cardiology Fellows. CJGIM 2012, Volume 7, Issue 4, 122-126.

MEDICAL SCHOOL/RESIDENCY/FELLOWSHIP/QUALIFICATIONS

  • D.C.M. McGill University
  • Internal medicine residency, UBC
  • Adult cardiology fellowship, Université de Montréal
  • Advanced heart failure and transplantation fellowship, St-Paul’s Hospital, UBC
  • Cardiac rehabilitation and prevention fellowship, UBC
  • Fellow of the Royal College of Physicians of Canada (FRCPC)
  • Site director of the Vancouver Island Inherited Hypertrophic Cardiomyopathy clinic

HIGHLIGHTS/ACHIEVEMENTS/COMMUNITY SERVICE

  • Member of the secondary panel for the 2019 Canadian Cardiovascular Society Heart Failure guidelines update
  • Contributor to the 2017 Canadian Cardiovascular Society Heart Failure guidelines
  • CCS Bayer Vascular Award recipient in 2014